KHK-IN-8 is a reversible and ATP-competitive inhibitor of human hepatic KHK activity. It acts by efficiently blocking fructose-1-phosphate secretion. References: Wu KL, Hung CY, Chan JY, Wu CW. An increase in adenosine-5'-triphosphate (ATP) content in rostral ventrolateral medulla is engaged in the high fructose diet-induced hypertension. J Biomed Sci. 2014 Jan 27;28. doi: 10.1186/1423-0127-21-8. PubMed PMID: 24467657; PubMed Central PMCID: PMC3913325.

纯度：≥98%

CAS：1303469-70-6